Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Lexicon Pharmaceuticals, Inc. (LXRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.4000-0.0100 (-0.41%)
At close: 04:00PM EDT
2.4200 +0.02 (+0.83%)
After hours: 07:18PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 10/3/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.42
52-Week Change 3-49.69%
S&P500 52-Week Change 3-16.62%
52 Week High 36.3300
52 Week Low 31.3100
50-Day Moving Average 32.7502
200-Day Moving Average 32.5807

Share Statistics

Avg Vol (3 month) 31.61M
Avg Vol (10 day) 3599.32k
Shares Outstanding 5188.73M
Implied Shares Outstanding 6N/A
Float 878.06M
% Held by Insiders 11.03%
% Held by Institutions 177.94%
Shares Short (Sep 14, 2022) 44.02M
Short Ratio (Sep 14, 2022) 45.85
Short % of Float (Sep 14, 2022) 43.61%
Short % of Shares Outstanding (Sep 14, 2022) 42.13%
Shares Short (prior month Aug 14, 2022) 43.66M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:7
Last Split Date 3May 20, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-87,778.90%

Management Effectiveness

Return on Assets (ttm)-42.11%
Return on Equity (ttm)-93.04%

Income Statement

Revenue (ttm)109k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-85.00%
Gross Profit (ttm)-54.75M
EBITDA -95.25M
Net Income Avi to Common (ttm)-96.8M
Diluted EPS (ttm)-0.6140
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)61.97M
Total Cash Per Share (mrq)0.34
Total Debt (mrq)25.42M
Total Debt/Equity (mrq)35.89
Current Ratio (mrq)3.85
Book Value Per Share (mrq)0.47

Cash Flow Statement

Operating Cash Flow (ttm)-87.82M
Levered Free Cash Flow (ttm)-51.95M
Advertisement
Advertisement